C07C 259/08
Having carbon atoms of hydroxamic groups bound to carbon atoms of rings
Official title: having carbon atoms of hydroxamic groups bound to carbon atoms of rings other than six-membered aromatic rings
C07C259/08 (Having carbon atoms of hydroxamic groups bound to carbon atoms of rings) appears on 106 US grants and 77 published applications in this corpus.
Search patents in C07C- Granted patents
- 106
- Published applications
- 77
- Assignees
- 77
- Inventors
- 356
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 9 | 0 |
| 1993 | 0 | 0 |
| 1994 | 4 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 8 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 0 |
| 2002 | 7 | 3 |
| 2003 | 3 | 2 |
| 2004 | 3 | 9 |
| 2005 | 4 | 0 |
| 2006 | 4 | 3 |
| 2007 | 1 | 2 |
| 2008 | 1 | 1 |
| 2009 | 3 | 0 |
| 2010 | 0 | 1 |
| 2011 | 2 | 3 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 8 |
| 2015 | 2 | 4 |
| 2016 | 7 | 7 |
| 2017 | 7 | 7 |
| 2018 | 4 | 1 |
| 2019 | 4 | 6 |
| 2020 | 3 | 1 |
| 2021 | 1 | 3 |
| 2022 | 1 | 4 |
| 2023 | 0 | 1 |
| 2024 | 3 | 5 |
| 2025 | 5 | 3 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Cannabinoid derivatives and precursors, and asymmetric synthesis for same5 May 2026US 12,617,749 B2Kare Chemical Technologies Inc.
- Imaging histone deacetylases with a radiotracer using positron emission tomography9 Dec 2025US 12,491,270 B2The General Hospital Corporation
- Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors25 Nov 2025US 12,479,797 B2Jubilant Epicore LLC
- Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof7 Oct 2025US 12,435,051 B2Vivozon Inc.
- Herbicidal composition containing difluorobutenoic acid amide compound8 Jan 2026US 2026/0007131 A1Ishihara Sangyo Kaisha, Ltd.
- Mitofusin activators having an endocyclic-bonded carbonyl group and methods for use thereof30 Oct 2025US 2025/0332124 A1
- Small molecule inhibitors of enpp119 Jun 2025US 2025/0197383 A1The Regents of the University of California
- Dhodh inhibitors containing a carboxylic acid bioisostere27 Feb 2025US 2025/0066290 A1Immunic AG
- Dual modulator of mglur5 and 5-ht2a receptor, and use thereof31 Oct 2024US 2024/0360092 A1Vivozon Inc.
Most cited
By later US patents
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Potent inducers of terminal differentiation and methods of use thereof95US 5,369,108 ASloan-Kettering Institute for Cancer Research · 1994
- Potent inducers of terminal differentiation and methods of use thereof91US 6,087,367 ASloan-Kettering Institute for Cancer Research · 2000
- Potent inducers of terminal differentiation and method of use thereof89US 5,700,811 ASloan-Kettering Institute for Cancer Research · 1997
- Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents86US 7,071,355 B24 Sc AG · 2006